Research news: Pinpoint targeting instead of shotgun approach

News |

Integrins help cells communicate with and adapt to their environment. Also cancer cells depend on their properties to survive and spread throughout the body. Now TUM-IAS Carl von Linde Senior Fellow Horst Kessler, doctoral candidate Tobias Kapp and his colleague Dr. Oleg Maltsev have successfully developed a small, highly active molecule that binds to a specific integrin that operates in many types of cancer. In the future it may allow patient-specific diagnoses and subsequent targeted treatment of tumor cells.

A full press release can be found here.